Literature DB >> 12729918

Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question.

Christine Van Hoof1, Jozef Goris.   

Abstract

Protein phosphatase type 2A (PP2A) is a major Ser/Thr phosphatase involved in several cellular signal transduction pathways. In this review, we will focus on recent progress concerning the role of PP2A in apoptotic signalling. Since PP2A activates pro-apoptotic and inhibits anti-apoptotic proteins of the Bcl-2 family, we conclude that PP2A has a positive regulatory function in apoptosis. However, in Drosophila, a specific subset of the PP2A holoenzyme family, containing B'/PR61 as third regulatory subunit, is inhibitory for apoptosis, suggesting different regulatory mechanisms and substrates in different species. Moreover, PP2A acts not only upstream as a regulator of the apoptotic signal transduction pathway but also downstream as a substrate of effector caspases. Hence, PP2A is involved in the regulation as well as in the cellular response of apoptosis. Probably, various PP2A holoenzymes with distinct regulatory subunits specifically target different apoptotic substrates. This could explain the implication of PP2A at several levels of the apoptotic signal transduction pathway. Finally, some viral proteins such as adenovirus E4orf4 and simian virus small t target PP2A to alter its activity, resulting in induction of apoptosis as a regulatory mechanism to enhance virus spread.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729918     DOI: 10.1016/s0167-4889(03)00029-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

Review 1.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

2.  Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades.

Authors:  Lingaiah Hari Babu; Srinivasan Perumal; Maruthaiveeran Periyasamy Balasubramanian
Journal:  Cell Oncol (Dordr)       Date:  2012-06-22       Impact factor: 6.730

3.  Genetic modifier screens on Hairless gain-of-function phenotypes reveal genes involved in cell differentiation, cell growth and apoptosis in Drosophila melanogaster.

Authors:  Dominik Müller; Sabrina J Kugler; Anette Preiss; Dieter Maier; Anja C Nagel
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

4.  An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

Authors:  Chee Yeun Chung; James B Koprich; Shogo Endo; Ole Isacson
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

Authors:  Heng-Hong Li; Xin Cai; Geoffrey P Shouse; Landon G Piluso; Xuan Liu
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

6.  Subunit composition and developmental regulation of hepatic protein phosphatase 2A (PP2A).

Authors:  Sunny J-S Yoo; Joan M Boylan; David L Brautigan; Philip A Gruppuso
Journal:  Arch Biochem Biophys       Date:  2007-03-07       Impact factor: 4.013

7.  PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.

Authors:  Vivian R Ruvolo; Svitlana M Kurinna; Kul B Karanjeet; Todd F Schuster; Alberto M Martelli; James A McCubrey; Peter P Ruvolo
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

8.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.

Authors:  Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Anna M Eiring; Mario Notari; Bradley W Blaser; Shujun Liu; Rossana Trotta; Natarajan Muthusamy; Carlo Gambacorti-Passerini; Brian J Druker; Jorge Cortes; Guido Marcucci; Ching-Shih Chen; Nicole M Verrills; Denis C Roy; Michael A Caligiuri; Clara D Bloomfield; John C Byrd; Danilo Perrotti
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.

Authors:  Abedul Haque; Mohammad A Rahman; James R Fuchs; Zhuo Georgia Chen; Fadlo R Khuri; Dong M Shin; A R M Ruhul Amin
Journal:  Cancer Lett       Date:  2015-04-24       Impact factor: 8.679

Review 10.  Selective degradation of mitochondria by mitophagy.

Authors:  Insil Kim; Sara Rodriguez-Enriquez; John J Lemasters
Journal:  Arch Biochem Biophys       Date:  2007-04-12       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.